Prototheca, a genus of ubiquitous achlorophyllic
algae. It is a unicellular organism that reproduces asexually by internal
septation and cleavage, to form sporangia (6 to 26 mm
in diameter) containing sporangiospores. Prototheca is a ubiquitous
organism that lives saprophytically on decaying organic matter. It has
been recovered from fresh and marine water, fish tanks, swimming pools,
waste stabilization ponds, vegetables, and meat products such as beef,
pork, crabs, and clams
=> prototechosis : 90 cases mostly in immunocompromised patients,
mostly due to systemic or topical steroids
Epidemiology : the first case of multiorgan
systemic protothecal infection was described by Cox et al. in 1974. The
patient was a 29-year-old man who had involvement of the liver, peritoneum,
lymph nodes, skin, and blood. A similar case of visceral protothecosis,
in a 39-year-old man, was later described; the infection mimicked sclerosing
cholangitis. A third case of visceral protothecosis, in a 13-year-old Japanese
boy, was described in 1992. In this patient, the liver, spleen, small intestine,
lymph nodes, and central nervous system were involved. The other cases
of systemic protothecosis consisted of an AIDS patient with protothecal
meningitis, a Hickman catheter-related algaemia in a 7-year-old child on
chemotherapy for Hodgkin’s disease, and two cases of non-catheter-related
protothecal sepsis in patients with a lung transplant and leukemia, respectively.
In all but one, the species involved was P. wickerhamii. From the
lung transplant patient, P. zopfii was isolated. Systemic algaemia,
with recovery of Prototheca species from the blood, occurred in
only 5 cases, one associated with myasthenia gravis (papulonodular eruption
on his right hand, from which P. wickerhamii was subsequently isolated.
According to his wife, the patient had a persistent rash on his right hand
for approximately 6 to 8 weeks prior to admission. It is possible that
this initial rash was a localized mild infection due to P. wickerhamii,
which then disseminated as a systemic algaemia, when the patient suffered
an acute exacerbation of his myasthenia gravis. The role of the prior plasmapheresis
in the progression of his protothecal disease is unknown. Alternatively,
the cutaneous eruption could have resulted from hematogenous seeding of
a preceding algaemia. Prototheca species have previously been isolated
from stools, urine, and sputum. For our patient, urine and sputum cultures
were negative for Prototheca species; a stool specimen was not cultured
for Prototheca. Cultures of 4 additional intravenous catheter tips
were negative. The source of infection, in this patient, remains undetermined.ref)
chronic cutaneous and/or subcutaneous protothecosis (38%) : non-tender,
pyoderma-like or diffusely infiltrating erythematous papules and plaques
on the extensor side of the extremities (elbow and foot ) or face. Infections
of immunosuppressed patients tend to be more florid
The first case of human P. zopfii infection was described by
Davis et al. in 1964. The patient was a rice farmer in Sierra Leone with
a localized chronic skin lesion.
Therapy : local infiltration of fluconazole
3 ml (2 mg/ml)/week x 4.
Epidemiology : worldwide
Transmission : milk as well as dairy products
from infected Bos taurus,
where severe protothecal mastitis is a result of adventitious infection
from the environment
Laboratory examinations : typical endospores
with morula-like structures in skin biopsy specimens, PAS+,
Gomori's methenamine silver+, and Gridley fungus stain+.
Prototheca
species may be confused with yeasts such as Candida and Cryptococcus
species on Gram stains.
Therapy :
i.v. amphotericin B
> 5-fluorocytosine in cases of disseminated disease and in patients with
severe underlying illness or with immunosuppression or immunocompromise
azole antifungals and surgery should be reserved for patients with more
localized disease. Itraconazole
appears to be the most effective agent of this drug class, and it should
be administered at 200 mg/day for 2 months.